Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2021 | Prevention of maternal antibody-mediated diseases

Angela Vincent, MBBS (Hon PhD Bergen), FRCPath, FMedSci, FRS, University of Oxford, Oxford, UK, discusses the broad implications of using therapeutic monoclonal antibodies (mAbs) to prevent the trans-placental transfer of pathogenic antibodies in the prevention of maternal antibody-mediated diseases. New techniques and therapies are providing the opportunity for better research into these mechanisms. This interview took place during the European Academy of Neurology 2021 congress.


Prof. Vincent was a co-investigator on a small grant provided by UCB for the animal model work.